We will be able to see what Cook contributed after collecting half a million of free oopies when GSK report the Relenza sales results.
Roches reporteda 262 million CHF Tamiflu sales .
Totals sales 262 million CHF down 58%
This is made up of 178 m CHF (USA); 9 m CHF Western Europe; 51m CHF - Japan; 24 m CHF - rest of international.
http://www.roche.com/investors/ir_update/inv-update-2011-07-21.htm
There is an increase in flu resistance to Tamiflu. Cook told shareholders he settled to normalise relationship with GSK and the new GSK management team is enthusiastic about Relenza. So let us wait and see how Cook had contributed through GSK.
Add to My Watchlist
What is My Watchlist?